Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
• To evaluate the efficacy of GS-5745 to induce EBS clinical remission at Week 8 (Cohort 1) • To evaluate the efficacy of GS-5745 to maintain EBS clinical remission at Week 52 (Cohort 2) • To evaluate the safety and tolerability of GS-5745
Critère d'inclusion
- Ulcerative colitis